Biblio
Export 1532 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is H [Clear All Filters]
“Vascular Risk Factors and Alzheimer's Disease: Blood-Brain Barrier Disruption, Metabolic Syndromes, and Molecular Links.”, J Alzheimers Dis, vol. 73, no. 1, pp. 39-58, 2020.
, “Waist Circumference and Domain-Specific Cognitive Function Among Non-Demented Japanese Older Adults Stratified by Sex: Results from the Takashima Cognition Study.”, J Alzheimers Dis, vol. 73, no. 3, pp. 887-896, 2020.
, “Adverse Vascular Risk Relates to Cerebrospinal Fluid Biomarker Evidence of Axonal Injury in the Presence of Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 71, no. 1, pp. 281-290, 2019.
, “Alzheimer's and Parkinson's Diseases and the Risk of Cancer: A Cohort Study.”, J Alzheimers Dis, vol. 72, no. 4, pp. 1269-1277, 2019.
, “Alzheimer's and Parkinson's Diseases and the Risk of Cancer: A Cohort Study.”, J Alzheimers Dis, vol. 72, no. 4, pp. 1269-1277, 2019.
, “Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer's Disease-Matched Cohort Study.”, J Alzheimers Dis, vol. 68, no. 1, pp. 127-136, 2019.
, “APOE Effect on Amyloid-β PET Spatial Distribution, Deposition Rate, and Cut-Points.”, J Alzheimers Dis, vol. 69, no. 3, pp. 783-793, 2019.
, “The Association between Mushroom Consumption and Mild Cognitive Impairment: A Community-Based Cross-Sectional Study in Singapore.”, J Alzheimers Dis, vol. 68, no. 1, pp. 197-203, 2019.
, “A Brief Ischemic Postconditioning Protects Against Amyloid-β Peptide Neurotoxicity by Downregulating MLK3-MKK3/6-P38MAPK Signal in Rat Hippocampus.”, J Alzheimers Dis, vol. 71, no. 2, pp. 671-684, 2019.
, “CD14 and Toll-Like Receptor 4 Promote Fibrillar Aβ42 Uptake by Microglia Through A Clathrin-Mediated Pathway.”, J Alzheimers Dis, vol. 68, no. 1, pp. 323-337, 2019.
, “Cerebral Microbleeds Are Associated with Cerebral Hypoperfusion in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 71, no. 1, pp. 273-280, 2019.
, “Cerebral Microbleeds Are Associated with Cerebral Hypoperfusion in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 71, no. 1, pp. 273-280, 2019.
, “Choroid Plexus Acts as Gatekeeper for TREM2, Abnormal Accumulation of ApoE, and Fibrillary Tau in Alzheimer's Disease and in Down Syndrome Dementia.”, J Alzheimers Dis, vol. 69, no. 1, pp. 91-109, 2019.
, “Choroid Plexus Acts as Gatekeeper for TREM2, Abnormal Accumulation of ApoE, and Fibrillary Tau in Alzheimer's Disease and in Down Syndrome Dementia.”, J Alzheimers Dis, vol. 69, no. 1, pp. 91-109, 2019.
, “Circulating and Extracellular Vesicles Levels of N-(1-Carboxymethyl)-L-Lysine (CML) Differentiate Early to Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 69, no. 3, pp. 751-762, 2019.
, “The Clinical Phenotype of Vascular Cognitive Impairment in Patients with Type 2 Diabetes Mellitus.”, J Alzheimers Dis, vol. 68, no. 1, pp. 311-322, 2019.
, “Distinctive Neurochemistry in Alzheimer's Disease via 7 T In Vivo Magnetic Resonance Spectroscopy.”, J Alzheimers Dis, vol. 68, no. 2, pp. 559-569, 2019.
, “Distinctive Neurochemistry in Alzheimer's Disease via 7 T In Vivo Magnetic Resonance Spectroscopy.”, J Alzheimers Dis, vol. 68, no. 2, pp. 559-569, 2019.
, “Education Moderates the Relation Between APOE ɛ4 and Memory in Nondemented Non-Hispanic Black Older Adults.”, J Alzheimers Dis, vol. 72, no. 2, pp. 495-506, 2019.
, “Evaluation of Associations of Alzheimer's Disease Risk Variants that Are Highly Expressed in Microglia with Neuropathological Outcome Measures.”, J Alzheimers Dis, vol. 70, no. 3, pp. 659-666, 2019.
, “Exercise Training in Amnestic Mild Cognitive Impairment: A One-Year Randomized Controlled Trial.”, J Alzheimers Dis, vol. 71, no. 2, pp. 421-433, 2019.
, “Exercise Training in Amnestic Mild Cognitive Impairment: A One-Year Randomized Controlled Trial.”, J Alzheimers Dis, vol. 71, no. 2, pp. 421-433, 2019.
, “A Fragment of S38AA is a Novel Plasma Biomarker of Alzheimer's Disease.”, J Alzheimers Dis, vol. 71, no. 4, pp. 1163-1174, 2019.
, “Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer's Disease and Correlates with Cognitive Impairment.”, J Alzheimers Dis, vol. 67, no. 2, pp. 481-488, 2019.
, “Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer's Disease and Correlates with Cognitive Impairment.”, J Alzheimers Dis, vol. 67, no. 2, pp. 481-488, 2019.
,